Literature DB >> 33778477

Nonsurgical Treatment Options for Muscle Contractures in Individuals With Neurologic Disorders: A Systematic Review With Meta-Analysis.

Christian Svane1,2, Jens Bo Nielsen1,2, Jakob Lorentzen1,2.   

Abstract

OBJECTIVE: To investigate whether nonsurgical treatment can reduce muscle contractures in individuals with neurologic disorders. The primary outcome measure was muscle contractures measured as joint mobility or passive stiffness. DATA SOURCES: Embase, MEDLINE, Cumulative Index to Nursing and Allied Health, and Physiotherapy Evidence Database in June-July 2019 and again in July 2020. STUDY SELECTION: The search resulted in 8020 records, which were screened by 2 authors based on our patient, intervention, comparison, outcome criteria. We included controlled trials of nonsurgical interventions administered to treat muscle contractures in individuals with neurologic disorders. DATA EXTRACTION: Authors, participant characteristics, intervention details, and joint mobility/passive stiffness before and after intervention were extracted. We assessed trials for risk of bias using the Downs and Black checklist. We conducted meta-analyses investigating the short-term effect on joint mobility using a random-effects model with the pooled effect from randomized controlled trials (RCTs) as the primary outcome. The minimal clinically important effect was set at 5°. DATA SYNTHESIS: A total of 70 trials (57 RCTs) were eligible for inclusion. Stretch had a pooled effect of 3° (95% CI, 1-4°; prediction interval (PI)=-2 to 7°; I 2=66%; P<.001), and robot-assisted rehabilitation had an effect of 1 (95% CI, 0-2; PI=-8 to 9; I 2=73%; P=.03). We found no effect of shockwave therapy (P=.56), physical activity (P=.27), electrical stimulation (P=.11), or botulinum toxin (P=.13). Although trials were generally of moderate to high quality according to the Downs and Black checklist, only 18 of the 70 trials used objective measures of muscle contractures. In 23 trials, nonobjective measures were used without use of assessor-blinding.
CONCLUSIONS: We did not find convincing evidence supporting the use of any nonsurgical treatment option. We recommend that controlled trials using objective measures of muscle contractures and a sufficiently large number of participants be performed.
© 2021 The Authors.

Entities:  

Keywords:  BTX, botulinum toxin; CCT, controlled clinical trial; Contracture; Nervous System Diseases; PI, prediction interval; PICO, patient, intervention, comparison, outcome; PROM, passive range of motion; RCT, randomized controlled trial; Range of motion, articular; Rehabilitation

Year:  2021        PMID: 33778477      PMCID: PMC7984980          DOI: 10.1016/j.arrct.2021.100104

Source DB:  PubMed          Journal:  Arch Rehabil Res Clin Transl        ISSN: 2590-1095


Muscle contractures are a common complication of neurologic disorders such as stroke, spinal cord injury, multiple sclerosis, and cerebral palsy. The prevalence has been reported to range from 36%-60%.1, 2, 3, 4, 5 Muscle contractures represent a unique muscle adaptation characterized by increased passive stiffness of the muscle and limited mobility of the joint with little or no active force production. Muscle contractures lead to joints fixated in abnormal positions and limited use of the affected limbs. Furthermore, muscle contractures can cause considerable pain, strength loss, and muscle atrophy., To restore the mobility of affected joints, surgical procedures such as various forms of tendon lengthening and intramuscular aponeurotic recession are used., These procedures may increase the range of motion for some time, but because they rarely have lasting effects, other effective treatment approaches should be considered also. A variety of other treatment options currently exists. A few of these have previously been reviewed (stretching and shockwave therapy,), but a systematic evaluation of the effectiveness of all the available nonsurgical treatment options in a single review has so far not been conducted. A critical and comprehensive evaluation of the effect of all treatment options in 1 single study may help clinicians to obtain a better overview of the field. It may also help to clarify where the existing knowledge needs to be strengthened by further research and point to new therapy options. Therefore, the aim of this systematic review was to provide an overview of the evidence supporting the use of current nonsurgical treatment options for reduction of muscle contractures in individuals with neurologic disorders. We included randomized controlled trials (RCTs) and controlled clinical trials (CCTs) of nonsurgical interventions administered with the aim to treat muscle contractures in individuals with neurologic disorders. We decided to include not only RCTs but also CCTs because we wanted to review all available treatment options. The primary outcome measure was muscle contractures measured as either joint mobility or passive stiffness.

Methods

Study design

We conducted this systematic review with meta-analyses of RCTs and CCTs using a protocol based upon Cochrane Collaboration recommendations and reported it according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement.,

Eligibility criteria

Published trials fulfilling the following patient, intervention, comparison, outcome (PICO) criteria were included.

Participants

Individuals of all ages and sexes with muscle contractures due to a neurologic disorder.

Interventions

Nonsurgical interventions administered to treat muscle contractures.

Comparisons

Trials that compared the intervention with a control condition. Control condition included no intervention, usual care, and placebo/sham treatment.

Outcomes

The main outcome was muscle contractures measured as either passive range of motion (PROM) or passive stiffness.

Search strategy

Relevant articles were identified by searching the databases of Embase, MEDLINE, Cumulative Index to Nursing and Allied Health, and Physiotherapy Evidence Database, using a combination of subject headings and free-text terms. The search string was initially developed for MEDLINE and adapted for use in the other databases. Search strings used in all databases can be found in the supplemental table S1 (available online only at http://www.archives-pmr.org/). Publications were limited to the English language. Publications were not limited by year of publication. We performed the search in June-July 2019. We additionally searched all databases in July 2020 to detect any eligible trials published during the review process.

Data extraction

Two review authors (C.S., J.L.) screened title and abstracts of all records obtained from the searches and excluded irrelevant articles. Full texts of the remaining articles were then obtained and screened for eligibility based on our PICO criteria by the 2 review authors (C.S., J.L.). Through subjective judgment, the reviewers doing the data extraction decided whether the intervention was administered to treat muscle contractures. Disagreements were solved by discussion and, when necessary, arbitrated by a third review author (J.B.N.) deciding whether to include or exclude the disputed.

Data synthesis

C.S. extracted short-term joint mobility data (up to 1wk after intervention). Preferably, change scores and SDs were extracted. If change scores were not available, postintervention scores were used instead. Change scores/postintervention scores and SDs were not available for all trials. In trials where this information was not available, we contacted the corresponding author of the article in an attempt to retrieve the information. Several trials investigated the effect of the intervention on multiple joints and/or both sides. In these cases, we used data from a single joint on the right side of the body. In prioritized order, we chose to use data from the ankle joint, the elbow joint, the knee joint, or the wrist joint. This order was based on our experience of where muscle contractures are frequent and severe and is in accordance with literature on muscle contracture prevalence in different neurologic disorders.1, 2, 3 We identified 6 types of interventions with multiple trials: stretch, shockwave therapy, physical activity, botulinum toxin (BTX) treatment, electrical stimulation, and robot-assisted rehabilitation interventions. Based on the recommendations by Valentine et al, we conducted individual meta-analyses for these 6 intervention types. Because very few trials used passive stiffness as an outcome measure, the meta-analyses were performed based on PROM results. The primary outcome measure was set as the pooled PROM from RCTs. For all intervention types, we conducted sensitivity analyses to examine the effects of randomization on joint mobility. Similarly to Harvey et al, we did not consider a treatment effect of <5° PROM as clinically important. Because we considered the included trials to have varying effect sizes, all meta-analyses were performed using a random-effects model. In accordance with the Cochrane Handbook for Systematic Reviews of Intervention, we reported the effects using mean differences in the meta-analysis in cases where the outcome was reported using comparable measures. In 1 case with robot-assisted rehabilitation, the outcome was not measured using comparable methods. Here, we reported the effect of the intervention using standardized mean differences in the meta-analysis. In forest plots, randomized and nonrandomized trials are presented separately. Subgroup analyses were used to explore possible differences between types of stretch. In studies with several relevant experimental groups (2 types of stretch protocols), we combined the experimental groups in to 1 single group. Prediction intervals were calculated in accordance with the method described by Borenstein. Meta-analyses were conducted using Review Manager 5.3.a We assessed trials for risk of bias using the Downs and Black checklist. Initially, 2 review authors (C.S., J.L.) scored the first trials together to synchronize the interpretation of the checklist. Subsequently, C.S. and J.L. scored the remaining trials independently. The maximum score attainable using the Downs and Black checklist is 33 points. The quality of included trials was ranked as high if the total score was >75% of the maximum, moderate if 60%-74% of the maximum, and low if <60% of the maximum., In question 20 we focused on whether the primary outcome measure was objective. We defined an objective measure as a measure not easily influenced by the rater. All torque-controlled goniometric measures were defined as objective, whereas noncontrolled goniometric were not. As we were interested in whether joint mobility was measured objectively and by use of blinded assessors to not introduce bias, we focused in particular on question numbers 15 and 20.

Ethics and registration

This study did not require ethical approval. The systematic review protocol was prospectively registered in the PROSPERO international prospective register of systematic reviews under registration number CRD42019140424.

Results

Study selection

The review process is explained in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses diagram (fig 1). We excluded 243 full-text articles because the trials did not fulfill our PICO criteria (211); because the full text was not available (12), not accessible (14), or was a duplicate (3); or because the primary data/summary statistics was not presented (3). The remaining 70 articles were included in this systematic review. Of the 70 articles included in the review, 57 were RCTs (see fig 1).
Fig 1

Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram.

Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram. Forest plot showing the mean difference with 95% CI for short-term effects of stretch on joint mobility. Forest plot with subgroups showing the mean difference with 95% CI for short-term effects of stretch on joint mobility. Stretching includes interventions such as passive stretching and self-stretch protocols. Forest plot showing the mean difference with 95% CI for short-term effects of shock wave therapy on joint mobility. Forest plot showing the mean difference with 95% CI for short-term effects of physical activity on joint mobility. Forest plot showing the mean difference with 95% CI for short-term effects of BTX on joint mobility. Forest plot showing the mean difference with 95% CI for short-term effects of electrical stimulation on joint mobility. Forest plot showing the mean difference with 95% CI for short-term effects of robot-assisted rehabilitation on joint mobility. Of the included trials, there were 22 trials (19 RCTs) on stretch interventions, 6 trials (2 RCTs) on shockwave interventions, 8 trials (7 RCTs) on BTX interventions, 9 trials (5 RCTs) on electrical stimulation interventions, 10 trials (8 RCTs) on physical activity interventions, and 5 trials (5 RCTs) on robot-assisted interventions. We performed meta-analyses for all of these intervention types. Additionally, we found 10 trials investigating other interventions. These trials are described in the section “Other interventions.”

Study characteristics

Table 1 depicts the characteristics of the included studies, including information about the intervention, the number of participants, and the measure of muscle contractures.
Table 1

Characteristics of the included trials (n=71)

StudyParticipantsInterventionIntervention detailsn (Experimental Group)n (Control Group)Primary Outcome
Stretch
Fox et al19Elderly persons with cognitive and functional impairmentBed positioningBed positioning for 40 min, 4×/wk for 8 wk1212PROM of knee extension measured using a goniometer
Maas et al20Children with CPOrthosisFoot orthosis for 1 y1311PROM of ankle DF measured using a single digital inclinometer attached to a torque wrench
Copley et al21Adults with acquired brain injurySplintingIndividualized, thermoplastic resting mitt splint for 3 mo64Wrist and finger PROM measured using a goniometer
DeMeyer et al22Adults with strokeCasting/orthosisBivalve cast group wore custom fiberglass castPRAFO group wore off-the-shelf AFO.Wearing schedule of 8-12 h every night for ∼4 wk.PRAFO 14Bivalve cast 1319Ankle DF PROM measured using a standardized torque application
Beckerman et al23Adults with strokeOrthosisAFO for 15 wk1614PROM of ankle joint measured using a goniometer
Harvey et al24Adults with stroke/SCI/TBISplintingExperimental thumbs splinted into abduction. 8 h per night for 12 wk29 thumbs29 thumbsPROM of palmar measured using a standardized torque measure
Kerem et al25Adults with CPSplintingJohnstone pressure splints. 5 d/wk for 3 mo1717PROM of the lower extremity measured using a goniometer
Harvey et al26Adults with SCIPassive movementsPassive ankle for 10 min in the morning and 10 min in the evening, 5 d/wk for 6 mo2020PROM of ankle DF measured through application of standardized torque
Theis et al27Children with CPPassive stretch15 min (60-s repetitions) of ankle DF stretch 4 d/wk for 6 wk76Passive stiffness of triceps surae
Harvey et al28Adults with SCIPassive stretchPassive hamstring stretch for 30 min/d, 5 d/wk for 4 wk1411Hamstring muscle extensibility measured using a torque-controlled measure
Cheng et al29Children with CPRepetitive passive movementsKnee repetitive passive movement intervention, 3/wk for 8 wk1818PROM of knee joint measured using an electric goniometer
Lannin et al30Adults with strokeSplintingStatic, palmar resting mitt splint on a daily basis, for max 12 h/night for 4 wk1811PROM of wrist extension measured using a torque-controlled measure
Basaran et al31Adults with strokeSplintingStatic volar or dorsal splints for 5 wkVolar 13Dorsal 1312PROM of wrist extension measured using a goniometer
Moseley32Children and adults with TBICastingBelow-knee cast for 7 d99PROM of the ankle joint measured using a torque-controlled measure
Pradines et al33Adults with chronic hemiparesisPassive and active stretchGuided self-rehabilitation Contract program, consisting of daily self-stretch exercises for 1 y1211Maximal extensibility (XV1 of the Tardieu Scale) of several muscles (PROM) measured with a goniometer
Lee et al34Adults with strokePosterior talar glideDF of the ankle joint for 10 glides of 5 sets/d, 5 d/wk for 4 wk1717PROM of ankle joint measured using a digital goniometer
Harvey et al35Adults with tetraplegiaSplintingOne thump of each participant was splinted each night for 3 mo2020Extensibility of the flexor pollicis longus muscle measured with a standardized torque application
Hill36Children and adults with brain injuryCastingCasting for 1 mo1515PROM of casted joints measured using a goniometer
Lannin et al37Adults with strokeSplintingHand splints positioning wrist in 0-10° extension (neutral splint group) or 45° wrist extension (extension splint group) at night for 4 wkNeutral splint 20Extension splint 2121Muscle extensibility measured using a standardized torque measure
Smedes et al38Adults with strokeManual mobilization10-min manual mobilization of the wrist 2 d/wk for 6 wk99PROM of wrist extension measured using a goniometer
Horsley et al39Adults with strokePassive stretch30 min of self-assisted stretch of the wrist and finger flexors, 5 d/wk for 4 wk2020PROM of wrist extension measured using a torque-controlled measure
An and Jo40Adults with strokeTalocrural mobilizationTalocrural mobilization 3 sessions/wk for 5 wk. Each session consisted of 6 sets of 10 repetitions.1313DF PROM measured using a dynamometer
Electrical stimulation
Pool et al41Children with CPFES8-wk FES intervention, FES used at least 1 h/d 6 d/wk1212PROM of ankle DF measured using a goniometer
Pool et al42Children with CPFESFES device, which dorsiflexes the ankle during the swing phase of gait for at least 4 h/d, 6 d/wk for 8 wk1616PROM of ankle DF measured using a goniometer
Sabut et al43Adults with strokeFESFES for 20-30 minutes to the TA muscle of the paretic limb 5 d/wk for 12 wk2724PROM in the ankle joint measured using a goniometer
Bakaniene et al44Children with CPTranscutaneous electrical nerve stimulation/Mollii suitElectrical stimulation through the Mollii suit for 1 h/d, 3/wk for 3 wk88PROM of ankle and knee joint measured using a goniometer
Malhotra et al45Adults with strokeNMES30 min sessions of NMES to the wrist and finger extensors at least 2 times/d, 5 d/wk for 6 wk4545PROM at slow stretchPassive stiffness at slow stretch
Nakipoglu Yuzer et al46Adults with strokeFESFES for 30 min/d, 5 d/wk for a total of 20 sessions per patient1515PROM of wrist extension measured using a goniometer
Leung et al47Adults with TBIElectrical stimulationThe intervention group received 30-min tilt table standing with electrical stimulation to the ankle dorsiflexor muscles 5 d/wk and ankle splinting 12 h/d, at least 5 d/wk.Control group only received tilt table standing for 30 min, 3 times/wk.1718PROM of ankle DF measured with a torque-controlled measure
Sabut et al48Adults with strokeFESFES of the TA muscle for 30 min, 5 d/wk for 12 wk1614PROM of the ankle joint
Beaulieu et al49Adults with strokeRepetitive peripheral magnetic stimulationSingle session of repetitive peripheral magnetic stimulation99PROM of ankle DF
Shockwave therapy
Manganiotti and Amelio50Adults with strokeESWTAs single session of ESWT2020PROM of the wrist measured using a digital goniometer
Lee et al51Adults with strokeESWTA single session of ESWT1010PROM of the ankle joint measured using a goniometer
Wang et al52Children with CPESWT1 ESWT session per wk for 3 mo.3433PROM of the ankle joint measured using a goniometer
Gonkova et al53Children with CPESWTA single session of ESWT2525PROM of ankle joint
Moon et al54Adults with strokeESWT3 sessions of ESWT, 1 session/wk for 3 wk3030PROM of the ankle measured using a goniometer
Vidal et al55Adults with CPESWTGroup 1 received ESWT in the spastic muscle, group 2 received radial ESWT in the spastic muscle and in the antagonistic muscle. 3 sessions, 1-wk intervals.Group 1=14 musclesGroup 2=13 muscles13PROM of lower limbs measured using a goniometer
BTX
Love et al56Children with CPBotox1 session of Botox into gastrocsoleus and where clinically indicated also into tibialis posterior1212PROM of ankle joints measured using a goniometer
Hawamdeh et al57Children with CPBotox3 successive Botox injections at intervals of 3-4 mo4040PROM of ankle DF measured using a protractor goniometer
Rameckers et al58Children with congenital spastic hemiplegiaBotox1 session of Botox injections1010PROM of wrist and elbow extension measured with a Mie goniometer
Meythaler et al59Adults with strokeBotoxBotox with therapy or placebo injections with therapy. 12-wk intervention.2121PROM of elbow and wrist joint measured monthly using a goniometer
Tedroff et al60Children with CPBotoxTwo Botox injections at 6-mo intervals69PROM of multiple joints measured using a goniometer
Koman et al61Children with CPBotoxBotox injections at baseline and at wk 45658PROM of ankle joint measured using a goniometer
Schasfoort et al62Children with CPBotoxControl group received 12 wk of conventional rehabilitation, intervention group received 12 wk of rehabilitation plus Botox injections4124PROM of multiple joints measured using a Lafayette goniometer
El-Etribi et al63Children with CPBotoxBotox administered after baseline measurements2020Ankle joint PROM measured using goniometer
Physical activity
Horsley et al64Adults with strokeUpper limb trainingActive repetitive motor training by using the SMART Arm device for up to 1 h/d, 5 d/wk for 5 wk2525PROM of multiple joints measured using a digital goniometer and a torque-controlled measure
Scholtes et al65Children with CPResistance training12-wk program of functional PRE training, 3 times/wk for 60 min2425PROM of the multiple joints measured using a goniometer
Schmid et al66Adults with strokeYogaTherapeutic yoga sessions were delivered in group sessions for 1 h 2 times/wk for 8 wk3710PROM of hamstrings muscles measured using a goniometer
Rydwik et al67Adults with strokeExercise programExercise program including active and passive range of motion of the ankle with a portable device (Stimulo), 3 times/wk for 30 min, over a 6-wk period99PROM of ankle joint measured using a goniometer
Baik et al68Children with CPHorseback ridingTherapeutic horseback riding 60 min/d, 2 d/wk for 12 wk. Daily program consisted of 10 min of warm-up, 40 min of workout, and 10 min of cooldown.88PROM of hip joint measured using a goniometer
Lorentzen et al69Adults with CPTreadmill training30-min daily uphill gait training for 6 wk on a treadmill1211Passive stiffness of the ankle joint quantified using a stationary and hand-held dynamometer.The hand-held dynamometer also to assess the PROM of the ankle joint.
Kirk et al70Adults with CPResistance trainingResistance training, 3 times/wk for 12 wk1211Passive stiffness of ankle plantar flexors measured using a stationary dynamometer
An and Won71Adults with strokeMWM and WBE30 min of MWM or WBE 3 times/wk for 5 wkMWM 12WBE 810PROM of the ankle joint using a isokinetic dynamometer
Teixeira-Machado and DeSantana72Children with CPDance24 one-h sessions twice a wk for 3 m1314PROM of multiple joint measured using a goniometer
Hemachitara et al73Children with CPHorse riding1 session of horse riding using a horse riding simulator1212PROM of hip abduction measured using a goniometer
Robot-assisted rehabilitation
Mirbagheri et al74Adults with SCIRobotic-assisted step trainingThree 1-h robotic-assisted step training sessions/wk for 4 wk2323Intrinsic ankle stiffness measured as using torque/unit change in ankle position
Waldman et al75Adults with strokeStretch and active movementsA portable rehabilitation robot with controlled passive stretching and active movement training capabilities. 18 sessions, 3 times/wk for 6 wk1212Ankle DF PROM measured using the robotic device
Mirbagheri et al76Adults with SCIRobot-assisted locomotor training LOKOMATLOKOMAT training 3 d/wk for 4 wk2328Intrinsic dynamic stiffness of the ankle joint
Franceschini et al77Adults with strokeUpper limb rehabilitationUpper limb robot-assisted rehabilitation; 30 sessions, 5 d/wk for 6 wk2523PROM of shoulder and elbow joint
Sale et al78Adults with strokeRobot-assisted therapyThirty 45-min sessions, 5 d/wk for 6 wk, using the robotic system that supported arm movements2627PROM of the shoulder and elbow joint
Other
Rayegani et al79Adults with SCIPassive cyclingMotorized cycle that passively moved legs for 20 min, 3 times/wk for 2 mo3529PROM of multiple joints measured using a goniometer
Xu et al80Adults with strokeMT combined with neuromuscular electrical stimulationMT group received 30 min of MT training.Control group performed the same training but with nonreflecting side of the mirror.MT+NMES group combined MT with 30 min NMES.MT 23MT+NMES 2323PROM of ankle joint DF assessed using a goniometer
Lorentzen et al81Adults with TBINeural tension technique1 session of neural tension technique treatment1010Passive knee stiffness measured using the Neurokinetics RA1 Rigidity Analyzer
Mathew et al82Children with CPAntispastic medicationParticipants received A (placebo), B (0.5/1.0mg diazepam), or C (1.0/2.0mg diazepam) for 15-20 d6060PROM of ankle joint measured using a goniometer
Velasco et al83Children with CPPhysical therapy based on head movements and serious games10 sessions of gaming using the ENLAZA interface55Cervical PROM
Wayne et al84Adults with strokeAcupunctureTraditional Chinese acupuncture, twice a wk for 10 wk1617PROM of each major upper extremity joint
Cheng et al85Children with CPWhole body vibration8-wk whole body vibration intervention1616PROM of knee joint measured using an electrogoniometer
Fosdahl et al86Children with CPStretching and PRE16 wk of 3 weekly sessions of stretching and resistance training1720Passive popliteal angle registered as maximum passive extension of the knee measured using a goniometer
Takeuchi et al87Adults with cerebrovascular diseaseHI-LPNR and stretchingParticipants were randomized to 1 session of HI-LPNR, stretching, a combination, or a control groupHI-LPNR 10 stretching 10combination 1010PROM of ankle DF and passive resistive joint torque of ankle DF
Ghannadi et al88Dry needling1 session of dry needling1212PROM of dorsiflexors measured using a goniometer

Abbreviations: AFO, ankle-foot orthosis; CP, cerebral palsy; DF, dorsiflexion; ESWT, extracorporeal shock wave therapy; FES, functional electrical stimulation; HI-LPNR, high-intensity pulse irradiation with linear polarized near-infrared rays; MT, mirror therapy; MWM, mobilization with movement; NMES, neuromuscular electrical stimulation; PRE, progressive resistance exercise; SCI, spinal cord injury; TA, tibialis anterior; TBI, traumatic brain injury; WBE, weight-bearing exercise.

Characteristics of the included trials (n=71) Abbreviations: AFO, ankle-foot orthosis; CP, cerebral palsy; DF, dorsiflexion; ESWT, extracorporeal shock wave therapy; FES, functional electrical stimulation; HI-LPNR, high-intensity pulse irradiation with linear polarized near-infrared rays; MT, mirror therapy; MWM, mobilization with movement; NMES, neuromuscular electrical stimulation; PRE, progressive resistance exercise; SCI, spinal cord injury; TA, tibialis anterior; TBI, traumatic brain injury; WBE, weight-bearing exercise.

Evidence quality

Table 2 summarizes the quality assessments performed based on the Downs and Black checklist. Data are presented as the subtotal scores, the total score, and the quality ranking of all trials. Furthermore, the average score for the different intervention types are presented. For detailed scoring of each individual article, we refer to the supplemental table S2 (available online only at http://www.archives-pmr.org/).
Table 2

Risk of bias in the included trials assessed using the Downs and Black checklist

StudyReportingExternal ValidityInternal Validity: BiasInternal Validity: ConfoundingPowerTotalPercentageQuality
Stretch
Fox et al191035532679High
Maas et al201136632988High
Copley et al211034512370Moderate
DeMeyer et al221035532679High
Beckerman et al23733532164Moderate
Harvey et al241136653194High
Kerem et al251004332061Moderate
Harvey et al261036342679High
Theis et al27815321958Low
Harvey et al281025632679High
Cheng et al291003432061Moderate
Lannin et al30925532473Moderate
Basaran et al311015532473Moderate
Moseley32914522164Moderate
Pradines et al331015532473Moderate
Lee et al34903532061Moderate
Harvey et al351125432576High
Hill36613431752Low
Lannin et al37906532370Moderate
Smedes et al381023221958Low
Horsley et al391126632885High
An and Jo40913532164Moderate
Averages1025532371Moderate
Electrical stimulation
Pool et al41903331855Low
Pool et al42914632370Moderate
Sabut et al431033542576High
Bakaniene et al44904221752Low
Malhotra et al45925552679High
Nakipoglu Yuzer et al46904432061Moderate
Leung et al471015532473Moderate
Sabut et al48935432473Moderate
Beaulieu et al491006522370Moderate
Averages914432267Moderate
Shockwave therapy
Manganiotti and Amelio501125332473Moderate
Lee et al511036622782High
Wang et al521134352679High
Gonkova et al53614141648Low
Moon et al541004442267Moderate
Vidal et al55504331545Low
Averages925342266Moderate
Botox
Love et al561034542679High
Hawamdeh et al571024542576High
Rameckers et al58904522061Moderate
Meythaler et al59806442267Moderate
Tedroff et al601115422370Moderate
Koman et al61604351855Low
Schasfoort et al621015252370Moderate
El-Etribi et al63802331648Low
Averages914442266Moderate
Physical activity
Horsley et al641036642988High
Scholtes et al651135552988High
Schmid et al66902452061Moderate
Rydwik et al67905522164Moderate
Baik et al68802021236Low
Lorentzen et al691006532473Moderate
Kirk et al70905342164Moderate
An and Won71803321648Low
Teixeira-Machado and DeSantana721003532164Moderate
Hemachitara et al731105532473Moderate
Averages1014432266Moderate
Robot-assisted rehabilitation
Mirbagheri et al741025442576High
Waldman et al751035532679High
Mirbagheri et al76503341545Low
Franceschini et al771114642679High
Sale et al781005542473Moderate
Averages914542370Moderate
Other interventions
Rayegani et al791032552576High
Xu et al80935642782High
Lorentzen et al811116522576High
Mathew et al82736352473Moderate
Velasco et al83804411752Low
Wayne et al84905532267Moderate
Cheng et al85903331855Low
Fosdahl et al861114632576High
Takeuchi et al87803421752Low
Ghannadi et al88906632473Moderate
Risk of bias in the included trials assessed using the Downs and Black checklist For stretch interventions, 8 trials were of high quality, 11 trials of moderate quality, and 3 trials of low quality. For electrical stimulation interventions, 2 trials were of high quality, 5 trials of moderate quality, and 2 trials of low quality. For shockwave interventions, 2 trials were of high quality, 2 trials of moderate quality, and 2 trials of low quality. For BTX interventions, 2 trials were of high quality, 4 trials of moderate quality, and 2 trials of low quality. For physical activity interventions, 2 trials were of high quality, 6 trials of moderate quality, and 2 trials of low quality. For robot-assisted interventions, 3 trials were of high quality, 1 trial of moderate quality, and 1 trial of low quality (table 3).
Table 3

Assessment of outcome measures

StudyBlinded AssessorObjective Outcome Measure
Stretch
Fox et al19YesNo
Maas et al20YesYes
Copley et al21YesNo
DeMeyer et al22NoYes
Beckerman et al23Unable to determineNo
Harvey et al24YesYes
Kerem et al25NoNo
Harvey et al26YesYes
Theis et al27NoYes
Harvey et al28YesYes
Cheng et al29NoNo
Lannin et al30YesNo
Basaran et al31YesNo
Moseley32NoYes
Pradines et al33YesNo
Lee et al34NoNo
Harvey et al35YesYes
Hill36YesNo
Lannin et al37YesYes
Smedes et al38NoNo
Horsley et al39YesYes
An and Jo40Unable to determineNo
Electrical stimulation
Pool et al41NoNo
Pool et al42NoNo
Sabut et al43NoNo
Bakaniene et al44NoNo
Malhotra et al45YesYes
Nakipoglu Yuzer et al46Unable to determineNo
Leung et al47YesNo
Sabut et al48YesNo
Beaulieu et al49YesNo
Shockwave therapy
Manganiotti and Amelio50NoNo
Lee et al51YesNo
Wang et al52Unable to determineNo
Gonkova et al53YesUnable to determine
Moon et al54NoNo
Vidal et al55YesNo
Botox
Love et al56NoNo
Hawamdeh et al57NoNo
Rameckers et al58YesNo
Meythaler et al59YesNo
Tedroff et al60YesNo
Koman et al61YesUnable to determine
Schasfoort et al62YesNo
El-Etribi et al63NoNo
Physical activity
Horsley et al64YesYes
Scholtes et al65YesNo
Schmid et al66NoNo
Rydwik et al67YesNo
Baik et al68NoNo
Lorentzen et al69YesYes
Kirk et al70NoYes
An and Won71NoNo
Teixeira-Machado and DeSantana72YesNo
Hemachitara et al73YesNo
Robot-assisted rehabilitation
Mirbagheri et al74NoYes
Waldman et al75Unable to determineYes
Mirbagheri et al76NoYes
Franceschini et al77YesNo
Sale et al78YesNo
Other interventions
Rayegani et al79NoNo
Xu et al80YesNo
Lorentzen et al81YesYes
Mathew et al82YesNo
Velasco et al83Unable to determineNo
Wayne et al84YesNo
Cheng et al85NoNo
Fosdahl et al86YesNo
Takeuchi et al87NoNo
Ghannadi et al88YesNo

NOTE. The information in this table corresponds to the results of questions 15 and 20 in the Downs and Black checklist.

Assessment of outcome measures NOTE. The information in this table corresponds to the results of questions 15 and 20 in the Downs and Black checklist. Table 3 depicts the results of question numbers 15 and 20 of the Downs and Black checklist. Question number 15 concerns assessor blinding; question number 20 concerns whether joint mobility was measured objectively. The assessor was blinded in 39 trials and not blinded in 25 trials. We were unable to determine whether the assessor was blinded in 6 trials. We rated the primary outcome measure as objective in 18 trials and not objective in 50 trials. In 2 trials, we were unable to determine if the primary outcome measure was measured objectively. In 19 trials, joint mobility was measured using neither assessor blinding nor an objective measure. In 4 of the trials where we were unable to determine the use of assessor blinding, joint mobility was measured using a nonobjective measure.

Effect of stretch on joint mobility (fig 2, fig 3)

Short-term effect is defined as effects measured up to 1 week after the end of the intervention. Of the 22 trials investigating the short-term effect of stretch on joint mobility,19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40 we were able to obtain pre/post (±SD) measurements of PROM from 19 studies.19, 20, 21, 22,24, 25, 26,28, 29, 30, 31, 32, 33, 34, 35,37, 38, 39, 40 Three of these trials,, compared 2 types of stretch interventions with a control situation. For these trials, we combined the experimental groups into 1 single group. The short-term effect of stretch intervention on joint mobility was investigated by pooling data from 17 RCTs with available data. Stretch had a pooled effect of 3° (95% CI, 1-4°; prediction interval (PI)=−2 to 7°; I=66%; P<.001). To explore differences in types of stretch, we explored the use of subgroup analysis. Here, we divided RCT studies in a casting/splinting subgroup and a stretching subgroup (including passive stretching protocols, self-stretching protocols, etc) (see fig 3). The effect of casting/splinting was 2° (95% CI, 0-5°) and the effect of stretching was 3° (95% CI, 1-5°).
Fig 3

Forest plot with subgroups showing the mean difference with 95% CI for short-term effects of stretch on joint mobility. Stretching includes interventions such as passive stretching and self-stretch protocols.

Effect of shockwave therapy on joint mobility (fig 4)

Of the 6 included trials investigating the effect of shockwave therapy on joint mobility,50, 51, 52, 53, 54, 55 we were able to obtain pre/post (±SD) measurements of PROM from 5 studies.50, 51, 52, 53, 54, However, only 1 of these studies was an RCT. The single RCT study had a short-term effect of 2° (95% CI, −5 to 10°; P=.56).

Effect of physical activity on joint mobility (fig 5)

Of the 10 trials investigating the effect of physical activity,64, 65, 66, 67, 68, 69, 70, 71, 72, 73 we obtained pre/post (±SD) measurements of PROM from 9 studies.64, 65, 66, 67, 68, 69, 70, 71, 72 The short-term effect of physical activity on joint mobility was investigated by pooling data from 7 RCTs with available data. Physical activity had a pooled effect of 3° (95% CI, −2 to 8°; PI=−15 to 20°; I2=87%; P=.28).

Effect of BTX on joint mobility (fig 6)

Of the 8 included trials investigating the effect of BTX on joint mobility,58, 59, 60, 61, 62, 63, 64, 65 we were able to obtain pre/post (±SD) measurements of PROM from 6 studies.58, 59, 60, 61, 62, 63 The short-term effect of BTX on joint mobility was investigated by pooling data from 5 RCTs with available data. BTX had a pooled effect of 4° (95% CI, −1 to 8°; PI=−13 to 20°; I=85%; P=.13).

Effect of electrical stimulation on joint mobility (fig 7)

Of the 9 included trials investigating the effect of electrical stimulation on joint mobility,56, 57, 58, 59, 60, 61, 62, 63 we were able to obtain pre/post (±SD) measurements of PROM from 8 studies.41, 42, 43, 44, 45, 46, 47, The short-term effect of electrical stimulation on joint mobility was investigated by pooling data from 5 RCTs with available data. Electrical stimulation had a pooled effect of 3° (95% CI, −1 to 6°; PI=−8 to 13°; I2=78%; P=.11).

Effect of robot-assisted rehabilitation on joint mobility (fig 8)

Of the 5 included trials investigating the effect of robot-assisted rehabilitation on joint mobility,74, 75, 76, 77, 78 we were able to obtain pre/post (±SD) measurements of PROM from 3 studies.,, The short-term effect of robot-assisted rehabilitation on joint mobility was investigated by pooling data from 5 RCTs with available data. Robot-assisted rehabilitation had a pooled effect of 1 (95% CI, −0 to 2; PI=−8 to 9; I2=73%; P=.03).

Effect of other interventions on joint mobility

Of the 70 included trials, 10 were not of the abovementioned intervention types. Rayegani et al found significant improvements in hip and ankle PROM after a 2-month passive cycling intervention in individuals with spinal cord injury. Xu et al investigated the effect of 4 weeks of mirror therapy or mirror therapy plus neuromuscular electrical stimulation. Compared with a control group, they found a significant effect of both interventions on ankle dorsiflexion PROM. Mathew et al investigated the effect of the antispasticity drug diazepam in children with cerebral palsy. After 15-20 days of intervention, they found a significant increase in PROM in the group receiving a large dose of diazepam but not in groups receiving placebo treatment or low-dose treatment. Wayne et al investigated the effect of up to 20 sessions of traditional Chinese acupuncture in adults with chronic hemiparesis after stroke. After treatment, they found significant increases in some but not all PROM measures in the acupuncture group compared with the control group. Ghannadi et al investigated the effect of dry needling in adults with stroke and found significant improvements of dorsiflexion PROM after treatment compared with the control group. Trials investigating the effect of neural tension technique, serious games, whole body vibration, stretch combined with resistance training, and high-intensity pulse irradiation with near-infrared rays found no significant effects on joint mobility.

Sensitivity analysis

Table 4 depicts the results of the sensitivity analyses. In the sensitivity analyses, we examined the effect of randomization.
Table 4

Sensitivity analyses

VariablesIntervention Type
StretchShockwave TherapyPhysical ActivityBotoxElectrical StimulationRobot-Assisted Rehabilitation
Pooled effect5° (2 to 7°) n=1912° (4 to 21°) n=43° (−1 to 7°) n=92° (−2 to 7°) n=63° (1 to 6°) n=81° (0 to 2°) n=3
Randomization (studies with adequate sequence allocation)3° (1 to 4°) n=172° (−5 to 10°) n=13° (−2 to 8°) n=74° (−1 to 8°) n=53° (−1 to 6°) n=51° (0 to 2°) n=3

NOTE. Pooled effect with all studies included in the analysis and with only randomized trials included. Results are presented as mean difference/standardized mean difference (95% CI). n=no. of studies included in analysis.

Sensitivity analyses NOTE. Pooled effect with all studies included in the analysis and with only randomized trials included. Results are presented as mean difference/standardized mean difference (95% CI). n=no. of studies included in analysis.

Discussion

In this systematic review, we aimed to determine whether the existing literature supports that nonsurgical treatment options can reduce muscle contractures in individuals with neurologic disorders. Through our systematic search, we found 70 trials (57 RCTs) eligible for inclusion; 22 trials (19 RCTs) on stretch interventions, 6 trials (2 RCTs) on shockwave interventions, 8 trials (7 RCTs) on BTX interventions, 9 trials (5 RCTs) on electrical stimulation interventions, 10 trials (8 RCTs) on physical activity interventions and 5 trials (5 RCTs) on robot-assisted interventions. Additionally, there were 10 single trials on other intervention types. Through meta-analysis and quality assessment, we did not find convincing evidence supporting the use of any nonsurgical treatment option. Similarly to Harvey et al, we do not consider a treatment effect of <5° PROM as clinically important. From the only available RCT on shockwave therapy, we found a nonsignificant effect of 2°. By including the 4 available nonrandomized studies, there was a significant effect of 12° (CI, 4-21°) (see fig 4 and table 4). Based on the Downs and Black checklist, 1 trial was of low quality, 2 were of medium quality, and 2 were of high quality. Perhaps more importantly, 2 of the 5 trials used neither assessor blinding nor an objective measure of joint mobility, thus introducing a large possibility of bias. The trial reporting the largest short-term effect (30°) did not use assessor blinding, an objective measure of joint mobility, or randomization. Four of the 5 trials measured PROM of the ankle joint, 1 measured PROM of the wrist. Four studies used a single session of shockwave therapy, and 1 study used 3 sessions of shockwave therapy. Because of limited data, we were not able to investigate the long-term effect of shockwave treatment through meta-analysis. However, 4 trials did in fact investigate possible sustained effects at follow-up intervals.,,, Gonkova et al found an immediate significant effect of 14° after shockwave treatment; after 4 weeks the effect was 11° and still significant compared with before treatment. Moon et al found a significant 30° effect of the shockwave intervention; at the 4-week follow-up the effect was 20°, and at the 12-week follow-up the effect was 10°. They found significant differences between baseline and measurements immediately after and 4 weeks after intervention. They did not find a statistical difference between baseline and 12-week follow-up measurements. Manganotti et al found an immediate nonsignificant effect of 3°; at the 4-week follow-up this difference was 4° and still nonsignificant compared with baseline. Lee et al found an immediate nonsignificant difference in joint mobility of 2.33° between the control group and the shockwave group; at the 4-week follow-up this difference was 3.55° and still nonsignificant. Because all indications concerning the effect of shockwave therapy are based on only a few trials of limited quality, we encourage cautious interpretations of the results.
Fig 4

Forest plot showing the mean difference with 95% CI for short-term effects of shock wave therapy on joint mobility.

From RCTs on stretch and robot-assisted rehabilitation interventions, we found small, clinically nonimportant effects on joint mobility. The estimated effect of stretch interventions was 3° PROM (CI, 1-4°). This finding is roughly consistent with that of the most recent systematic Cochrane review on the effect of stretch interventions on joint mobility in individuals with neurologic disorders by Harvey et al. Harvey found no short-term effect of stretch (mean difference=2° (95% CI, 0-3°). The estimated effect of robot-assisted rehabilitation interventions was 1° PROM (95% CI, 0-2°). We did not find significant effects from RCTs on physical activity (P=.27), electrical stimulation (P=.11), or BTX interventions (P=.13) on joint mobility. An important finding of this review was the lack of objective measures of muscle contractures found in many trials. Only 18 of the 70 included trials used objective measures of muscle contractures such as passive stiffness or torque-controlled goniometric measurements; most of these were trials investigating the effect of stretch. The remaining 52 trials measured PROM using primarily standard, non–torque-controlled goniometric measurements. Furthermore, these nonobjective measures were used in 23 trials without convincing use of assessor blinding, thus introducing a large possibility of bias. In future research in this field, we strongly advocate the use of objective, instrumented measures such as passive stiffness (eg, measured using the portable stiffness assessment device) or torque-controlled goniometric measurements.

Study limitations

As with all systematic review studies, there is a possibility of retrieval bias—the fact that potentially eligible trials might have been missed. To minimize retrieval bias we chose to use a broad search string, which we tested by its ability to identify already known eligible trials. This strategy resulted in a large amount of identified trials, but we hope that it minimized the amount of missed trials. We are aware of the fact that the inclusion of nonrandomized studies introduces a possibility for bias. To address this issue we based conclusions primarily on meta-analyses performed on RCTs only and performed sensitivity analyses investigating the effect of randomization. In the data extraction process, the reviewers doing the data extraction used subjective judgment to determine if the intervention was administered to treat muscle contractures. We acknowledge that doing this without objective and clear criteria is problematic but believe that this was the best possible solution. In the meta-analyses, we combined data from studies on different joints using absolute PROM measures. Although range of motion does differ between joints, we decided to maintain the use of an absolute outcome measure to ensure easy transferability and interpretation in a clinical setting. In all included trials, the severity of contractures at baseline may affect the effect of the intervention. Unfortunately, we were not able to quantify the severity of contractures at baseline because the included trials used different measurement tools, investigated different joints, etc. Similarly, past treatment history is likely to influence the effect of the intervention. Because only a very limited number of studies included information on treatment history, we were not able to include this information. This is therefore a limitation to the study. A possibility of bias is also introduced because 2 of the authors (J.L., J.B.N.) of this review were also authors of included trials. We addressed this possibility of bias by not letting authors extract data from trials in which they had been involved. Despite the fact that all trials were screened by 2 authors and arbitrated by a third review author in case of unsolvable disagreement, we acknowledge the possibility of selection bias in systematic reviews such as this.

Conclusions

The central findings of this systematic review are that effective, nonsurgical treatment of muscle contractures is yet to be convincingly achieved and that there is a need for the use of objective measures of muscle contractures. Future research in this field should focus on the use of an objective measure of muscle contractures, thereby increasing the validity of the trials. We believe that the implementation of such objective measures would advance the continued search for effective, nonsurgical treatment of muscle contractures in individuals with neurologic disorders.

Supplier

Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
  88 in total

1.  Botulinum toxin type A improved ankle function in children with cerebral palsy and dynamic equinus foot deformity.

Authors:  M J Goldberg
Journal:  J Bone Joint Surg Am       Date:  2000-06       Impact factor: 5.284

2.  The effect of exercise of the affected foot in stroke patients--a randomized controlled pilot trial.

Authors:  Elisabeth Rydwik; Sara Eliasson; Gunnar Akner
Journal:  Clin Rehabil       Date:  2006-08       Impact factor: 3.477

Review 3.  Surface electromyography (sEMG) of extradiaphragm respiratory muscles in healthy subjects: A systematic review.

Authors:  Elis E A Cabral; Guilherme A F Fregonezi; Luana Melo; Nada Basoudan; Sunita Mathur; W Darlene Reid
Journal:  J Electromyogr Kinesiol       Date:  2018-07-19       Impact factor: 2.368

4.  Radial extracorporeal shock wave therapy (rESWT) in the treatment of spasticity in cerebral palsy: a randomized, placebo-controlled clinical trial.

Authors:  Xavier Vidal; Antonio Morral; Lluís Costa; Miriam Tur
Journal:  NeuroRehabilitation       Date:  2011       Impact factor: 2.138

5.  Effectiveness of a bed positioning program for treating older adults with knee contractures who are institutionalized.

Authors:  P Fox; J Richardson; B McInnes; D Tait; M Bedard
Journal:  Phys Ther       Date:  2000-04

6.  Noninvasive neurostimulation in chronic stroke: a double-blind randomized sham-controlled testing of clinical and corticomotor effects.

Authors:  Louis-David Beaulieu; Hugo Massé-Alarie; Brenda Brouwer; Cyril Schneider
Journal:  Top Stroke Rehabil       Date:  2015-01-28       Impact factor: 2.119

7.  Hand splinting for poststroke spasticity: a randomized controlled trial.

Authors:  Aynur Basaran; Ufuk Emre; Kiymet Ikbal Karadavut; Ozlem Balbaloglu; Nercivan Bulmus
Journal:  Top Stroke Rehabil       Date:  2012 Jul-Aug       Impact factor: 2.119

8.  The effect of botulinum toxin type-A injection on spasticity, range of motion and gait patterns in children with spastic diplegic cerebral palsy: an Egyptian study.

Authors:  M A El-Etribi; M E Salem; H M El-Shakankiry; A M El-Kahky; S M El-Mahboub
Journal:  Int J Rehabil Res       Date:  2004-12       Impact factor: 1.479

9.  The effects of horseback riding participation on the muscle tone and range of motion for children with spastic cerebral palsy.

Authors:  Kwang Baik; Jung-Kyun Byeun; Jae-Keun Baek
Journal:  J Exerc Rehabil       Date:  2014-10-31

10.  The orthotic and therapeutic effects following daily community applied functional electrical stimulation in children with unilateral spastic cerebral palsy: a randomised controlled trial.

Authors:  Dayna Pool; Jane Valentine; Natasha Bear; Cyril J Donnelly; Catherine Elliott; Katherine Stannage
Journal:  BMC Pediatr       Date:  2015-10-12       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.